Rationale for Earlier Treatment in COPD: A Systematic Review of Published Literature in Mild-to-Moderate COPD
- 28 December 2012
- journal article
- review article
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 10 (1) , 79-103
Abstract
COPD is progressive and typically begins many years before a definite diagnosis is made. As the rate of decline in lung function may be faster in the initial stages of the disease, early intervention could be beneficial to control symptoms and affect disease progression and outcomes. A systematic review of published literature relating to mild-to-moderate COPD (patients with FEV1 ≥50% predicted) was performed to evaluate the level of impairment and natural history or disease progression over time, and impact of interventions on the outcomes of patients with early-stage disease. Of the 79 published articles included in this analysis, 31 reported randomized controlled trials; the remaining 48 articles reported studies of non-randomized and/or observational design. Nine of the randomized controlled trials were ≥6 months’ duration, enabling assessment of outcomes over time. Most of the randomized controlled trials were in patients with moderate COPD (GOLD stage II); few included patients with the mildest stages of the disease (i.e., stage I). The results show that even patients with milder or moderate COPD can have substantial limitations and physical impairment, which worsen over time. Encouragement of smoking cessation, in conjunction with management of symptoms and treating activity limitation and exacerbations by appropriate non-pharmacologic and pharmacologic management at the earliest possible stage, could positively affect the impact and progression of the disease.Keywords
This publication has 71 references indexed in Scilit:
- Preselection of patients at risk for COPD by two simple screening questionsRespiratory Medicine, 2010
- Physical inactivity in patients with COPD, a controlled multi-center pilot-studyRespiratory Medicine, 2010
- Cardiovascular Morbidity in COPD: A Study of the General PopulationCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2010
- Long-Term Outcomes in Mild/Moderate Chronic Obstructive Pulmonary Disease in the European Community Respiratory Health SurveyAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPDThorax, 2008
- COPD Stage and Risk of Hospitalization for Infectious Disease*Chest, 2008
- International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence studyThe Lancet, 2007
- Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice?Scandinavian Journal of Primary Health Care, 2006
- Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitisRespiratory Research, 2005
- An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stagesThorax, 2004